Special Offer: Get 50% off your first 2 months when you do one of the following
Personalized offer codes will be given in each session

The immune landscape of SARS-CoV-2-positive placentitis: a high dimensional, multiomic analysis.

About This Webinar

Purpose of this study: A small number of maternal SARS-CoV-2 infections are complicated by placentitis leading to obstetric complications including foetal growth restriction and/or intra-uterine death. The aim of this study is to understand the immunological processes that drive this potentially devastating condition.

Methods: FFPE tissue from 13 cases of placentitis from mothers with COVID-19, 6 diseased controls (chronic histiocytic villousitis (CHI) and villousitis of unknown origin (VUE)) and 5 normal placentas were examined by high-plex 32 marker immunohistochemistry (mIHC) on the Lunaphore COMET™ platform. Transcriptomic profiling was performed by RNAscope in-situ hybridisation (ISH), bulk gene expression sequencing (GES) and GeoMX digital spatial profiling (DSP).

Results: Direct SARS-CoV-2 infection of the trophoblast was demonstrated in 6/13 cases from SARS-CoV-2 positive mothers by mIHC (dual positivity for viral spike and nucleocapsid proteins) and confirmed by ISH and bulk GES. Virus was also detected within histiocytes consistent with virus phagocytosis. SARS-CoV-2+ cases of placentitis showed a predominantly histiocytic (CD68+) intervillous infiltrate with an associated smaller population of T-cells (CD3+) and B-cells (CD20+), distinguishing COVID-19 placentitis from diseased controls. GES showed upregulation of the CXCL10 and type I interferon pathways. CXCL10 expression within histiocytes was confirmed by mIHC and RNAscope.

Conclusion: SARS-CoV-2 can directly infect the placental villous trophoblast. SARS-CoV-2 placentitis is characterised by chronic histiocytic intervillousitis accompanied by high levels of CXCL10 production and activation of type I interferon signalling pathways. Overall, SARS-CoV-2 positive placentas showed a distinct immunopsthological phenotype compared to SARS-CoV-2 negative placentas from COVID-19 positive mothers and disease controls.

  • Approximately half of placentas from COVID-19 positive mothers with obstetric complications show direct infection of the trophoblast with SARS-CoV-2.
  • SARS-CoV-2+ COVID-19 placentitis shows a distinct immunopathological phenotype characterised by trophoblast necrosis, chronic histiocytic intervillousitis, T- & B-cell infiltrates & distinct cytikine profile.
  • Multiplex immunohistochemistry on the COMET™ platform combined with transcriptomic profiling can be used to validate novel markers and understand complex immunopathological phenomena.
Who can view: Everyone
Webinar Price: Free
Featured Presenters
Webinar hosting presenter
MRC Clinical Research Training Fellow, University of Birmingham, UK
Dr. Matthew Pugh is a pathologist specializing in diagnostic haematopathology and an MRC clinical research fellow at the University of Birmingham. His research interests include the immune controls of viruses including Epstein Barr virus and SARS-CoV-2.
Hosted By
Lunaphore Technologies webinar platform hosts The immune landscape of SARS-CoV-2-positive placentitis: a high dimensional, multiomic analysis.
Lunaphore Technologies's webinars
Attended (37)